Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis
NCT ID: NCT05248386
Last Updated: 2025-08-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
469 participants
INTERVENTIONAL
2022-08-26
2024-11-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee
NCT05449132
Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee
NCT05377489
A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain
NCT00394563
A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee
NCT04675034
A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain
NCT03081806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RTX-GRT7039
Participants will receive intra-articular injections of RTX-GRT7039 during the 52-week double-blind treatment period.
RTX-GRT7039
RTX-GRT7039 intra-articular injection.
Placebo
Participants will receive intra-articular injections of placebo matching to RTX-GRT7039 during the 52-week double-blind treatment period.
Placebo
Placebo matching RTX-GRT7039 intra-articular injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RTX-GRT7039
RTX-GRT7039 intra-articular injection.
Placebo
Placebo matching RTX-GRT7039 intra-articular injection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participant is 18 years of age or older at the Screening Visit.
* The participant has a diagnosis of osteoarthritis of the knee based on American College of Rheumatology criteria and functional capacity class of I to III.
* There is a documented history indicating that participant has insufficient pain relief with previous Standard of Care.
Exclusion Criteria
* The participant has a history of significant trauma or surgery (e.g., open or arthroscopic) to the index knee within 12 months of Screening.
* The participant has periarticular pain from any cause other than osteoarthritis, including referred pain, bursitis, or tendonitis.
* The participant has clinical hip osteoarthritis on the side of the index knee.
* The participant has pre-existing osteonecrosis, subchondral insufficiency fracture, atrophic osteoarthritis, severe bone on bone osteoarthritis, knee pain attributable to disease other than osteoarthritis, or the participant has rapidly progressing osteoarthritis (RPOA) Type I or Type II.
* The participant has significant malalignment of anatomical axis (medial angle formed by the femur and tibia) of the target knee (varus \>10, valgus \>10) by X-ray as assessed by independent Central Readers at Screening Visit.
* The participant has other conditions that could affect trial endpoint assessments of the index knee.
* The participant has current clinically significant disease(s) or condition(s) that may affect efficacy or safety assessments, or any other reason which, in the investigator's opinion, may preclude the participant's participation for the full duration of the trial.
* The participant has a history of hypersensitivity to resiniferatoxin (RTX) or any similar component (capsaicin, chili peppers).
* The participant is currently participating or was participating in another investigational drug trial within 3 months prior to the Screening Visit.
* The participant is an employee of the investigator or trial site, with direct involvement in the proposed trial or other trials under the direction of that investigator or trial site or is a family member of the employees or the investigator.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grünenthal GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cook Street Medical Clinic
Victoria, British Columbia, Canada
Dr. M. B. Jones
Victoria, British Columbia, Canada
Aggarwal and Associates Limited
Brampton, Ontario, Canada
Malton Medical Research
Mississauga, Ontario, Canada
GRMO (Groupe de Recherche en Rhumatologie et Maladies Osseuses) Inc.
Sainte-Foy, Quebec, Canada
Diex Research Sherbrooke Inc.
Sherbrooke, Quebec, Canada
Diex Recherche Victoriaville Inc.
Victoriaville, Quebec, Canada
Lekarna U Svate Anny
Písek, Czech Republic, Czechia
Revmatologie s.r.o.
Brno, , Czechia
Interni A Revmatologicka Ambulance
Břeclav, , Czechia
Vesalion s.r.o.
Ostrava, , Czechia
Revmatologicka Ambulance
Ostrava, , Czechia
Ortopedicko-traumatologicka ambulance
Písek, , Czechia
CCBR Czech Prague, s.r.o
Prague, , Czechia
CCR Prague, s.r.o
Prague, , Czechia
Revmatologicka ambulance
Prague, , Czechia
Thomayerova Nemocnice (TN)
Prague, , Czechia
Fakultni Thomayerova nemocnice s poliklinikou
Prague, , Czechia
Revmatologicka ambulance
Prague, , Czechia
EUC Klinika
Prague, , Czechia
Db Ortopedie s.r.o
Příbram, , Czechia
PV-MEDICAL s.r.o. Revmatologicka ambulance
Zlín, , Czechia
Centre Hospitalier Universitaire d'Amiens-Picardie - Site Sud
Amiens, , France
CHU Amiens Nord
Amiens, , France
Hopital Edouard Herriot
Lyon, , France
CHU Nimes Cedex
Nîmes, , France
Hopital Saint antoine
Paris, , France
Cochin Hospital-Paris Descartes University
Paris, , France
Hopitaux de Paris (AP-HP) - Groupe Hospitalier Cochin -Assistance Publique
Paris, , France
Hopital Lariboisiere,Hospitalier Universitaire Nord
Paris, , France
Praxis Dr. med. Stephan Grunert
Eichstätt, , Germany
Medizentrum Essen Borbeck
Essen, , Germany
HRF Hamburger Rheuma Forschungszentrum
Hamburg, , Germany
Ortho-Zentrum Karlsruhe
Karlsruhe, , Germany
Velocity Clinical Research Leipzig GmbH
Leipzig, , Germany
AmBeNet, Practice Dr. Dr. med. Hans-Detlev Stahl
Leipzig, , Germany
Centrum fuer Diagnostik und Gesundheit (CDG)
München, , Germany
Praxis-Reinfeld-Mitte
Reinfeld, , Germany
AOU-Careggi
Florence, , Italy
AOU-Careggi
Florence, , Italy
Universita degli Studi della Campania Luigi Vanvitelli - Azienda Ospedaliera Universitaria
Naples, , Italy
Dipartimento Di Scienze Ortopediche, Traumatologiche, Riabilitative E Plastico-Ricostruttive
Napoli, , Italy
IRCCS Istituto Clinico Humanitas
Rozzano, , Italy
AOU Citta della Salute e della Scienza di Torino
Torino, , Italy
Funabashi Municipal Medical Center
Funabashi-shi, Chiba, Japan
Kamagaya General Hospital
Kamagaya, Chiba, Japan
Hamanomachi Hospital
Fukuoka, Fukuoka, Japan
Souseikai Fukuoka Mirai Hospital
Fukuoka, Fukuoka, Japan
Seiwa-kai medical corporation Hiroshima clinic
Hiroshima, Hiroshima, Japan
Kosei General Hospital
Mihara, Hiroshima, Japan
Kosei General Hospital
Mihara-shi, Hiroshima, Japan
Hakodate Central General Hospital
Hakodate, Hokkaido, Japan
Sapporo Maruyama Orthopedic Hospital
Sapporo, Hokkaido, Japan
KKR Sapporo Medical Center
Sapporo, Hokkaido, Japan
Sapporo kotoni Orthopedies
Sapporo, Hokkaido, Japan
Kinashi Obayashi Hospital
Takamatsu, Kagawa-ken, Japan
Japan Organization of Occupational Health and Safety Yokohama Rosai Hospital
Yokohama, Kanagawa, Japan
Yokohoma Rosai Hospital
Yokohama, Kanagawa, Japan
Social Medical Care Corporation Hosei-kai Marunouchi Hospital
Nagano, Matsumoto-shi Nagano, Japan
KKR Tohoku Kosai Hospital
Sendai, Miyagi, Japan
Nakajo Orthopedic Clinic
Sendai, Miyagi, Japan
Marunouchi Hospital
Matsumoto, Nagano, Japan
KKR Tohoku Kosai Hospital
Aoba-ku, Sendai-shi, Japan
Otsu City Hospital
Ōtsu, Shiga, Japan
Shimane University Hospital
Izumo, Shimane, Japan
Shimane University Hospital
Izumo, Shimane, Japan
Japanese Red Cross Hamamatsu Hospital
Hamamatsu, Shizuoka, Japan
Juntendo University Hospital
Bunkyo-Ku, Tokyo, Japan
Juntendo University Graduate School of Medicine
Bunkyo-ku, Tokyo, Japan
Kitasato University Kitasato Institute Hospital
Minato-ku, Tokyo, Japan
Shirahama Hamayu Hospital
Nishimura, Wakayama, Japan
Juntendo University Hospital
Tokyo, , Japan
Medical Corporation Teda Ooimachi Orthopaedic Surgery and Surgery Clinic
Tokyo, , Japan
Morales Vargas Centro de Investigacion SC
León, Guanajuato, Mexico
Centro Integral en Reumatologia, SA de CV
Guadalajara, Jalisco, Mexico
Clinstile, S.A. de C.V
Cuauhtémoc, Mexico City, Mexico
Consultorio de Reumatologia
Gustavo Adolfo Madero, Mexico City, Mexico
CINTRE, Centro de Investigacion y Tratamiento Reumatologico S.C.
Mexico City, Mexico City, Mexico
Dr. Miguel Cortes Hernandez MD, Office of
Cuernavaca, Morelos, Mexico
Centro de Investigacion de Tratamientos Innovadores de Sinaloa S.C.
Culiacán, Sinaloa, Mexico
Investigacion y Biomedicina de Chihuahua
Chihuahua City, , Mexico
Medisch Spectrum Twente (MST) - Enschede Haaksbergerstraat
Enschede, KZ, Netherlands
PT&R
Beek, Limburg, Netherlands
Spaarne Gasthuis (Kennemer Gasthuis)
Hoofddorp, , Netherlands
Synexus Poznan Medical Center
Poznan, Greater Poland Voivodeship, Poland
Pratia MCM Krakow
Krakow, Lesser Poland Voivodeship, Poland
Reumed Spolka z o.o. Zespol poradni Specjalistycznych Filia Nr 1 Wallenroda
Lublin, Lublin Voivodeship, Poland
KO-MED Centra Kliniczne Lublin II
Zamość, Lublin Voivodeship, Poland
Makmed Nzoz
Nadarzyn, Masovian Voivodeship, Poland
NZOZ Lecznica MAK-MED S.C.
Nadarzyn, Masovian Voivodeship, Poland
Gabinet Internistyczno-Reumatologiczny Piotr Adrian Klimiuk
Bialystok, Podlaskie Voivodeship, Poland
Synexus Polska Sp. z o.o. Oddzial w Gdansku
Gdansk, Pomeranian Voivodeship, Poland
INTER CLINIC Piotr Adrian Klimiuk
Bialystok, , Poland
Synexus Gdynia
Gdynia, , Poland
Mazowieckie Centrum Badan Klinicznych
Grodzisk Mazowiecki, , Poland
Synexus Katowice Medical Center
Katowice, , Poland
Centrum Medyczne Pratia Katowice
Katowice, , Poland
Malopolskie Centrum Kliniczne
Krakow, , Poland
St Centrum Medyczne Plejady
Krakow, , Poland
Synexus Polska Sp. z o.o. Oddzial w Lodzi
Lodz, , Poland
KO-MED Centra Kliniczne Lublin II
Lublin, , Poland
Synexus Polska Spolka z ograniczona odpowiedzialnoscia Oddzial we Wroclawiu
Wroclaw, , Poland
Centrum Medyczne Kuba-Med Zamosc
Zamość, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-005029-26
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
U1111-1268-7314
Identifier Type: OTHER
Identifier Source: secondary_id
KF7039-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.